Repeat Offenders

Scanning the literature, scientists find that nearly 2 percent of papers contain duplicated and manipulated figures, among other image-prep no-nos.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PUBLICDOMAINPICTURES, LYNN GREYLINGThe duplication of images to serve more than one figure or bit of data happens—as anyone who frequents PubPeer can attest. Researchers now have some sense of just how often these repeats show up, at least among those papers that contain Western blots: 3.8 percent of publications, according to a preprint posted to BioRxiv April 20.

“The strength of their evidence should be enough to convince everyone that there is a major problem with how research is being conducted,” cell biologist David Vaux, who was not part of the duplication study, told Retraction Watch. “Now we need to determine what to do with this information.”

Stanford University microbiologist Elizabeth Bik and a pair of collaborators took on the laborious task of manually screening the figures of more than 20,000 studies published in any of 40 life science journals over the past decade. This meant Bik’s team had to look not only for repeats within the same figure, but across figures of the same paper as well.

The team categorized the copies as either simple duplication (29.4 percent), duplication with repositioning (45.5 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies